Changes in the quality of life of advanced melanoma patients after 12 weeks of treatment with ipilimumab compared to gp100 in a Phase III clinical trial

Authors:

Harvey B, Lee D, Gaudin A-F, Gueron B, Bregman B, Lebbé C and Borget I.

Publication Type:

Conference Proceedings – Poster

Publication Name:

American Society of Clinical Oncology (ASCO) Annual Meeting

Citation:

Harvey B, Lee D, Gaudin A-F, Gueron B, Bregman B, Lebbé C and Borget I. Changes in the quality of life of advanced melanoma patients after 12 weeks of treatment with ipilimumab compared to gp100 in a Phase III clinical trial. American Society of Clinical Oncology (ASCO) Annual Meeting. Chicago, United States of America. 31 May – 4 June. Poster 50C.

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies